Stability study of oral pediatric idebenone suspensions

Pharm Dev Technol. 2017 Mar;22(2):296-299. doi: 10.1080/10837450.2016.1231811. Epub 2016 Sep 21.

Abstract

Adapted forms for administration to infants are limited. The proposed study was performed to propose oral liquid formulations of idebenone in Ora-Plus and either Ora-Sweet or Ora-Sweet SF, Ora-Blend, Ora-Blend SF and Inorpha. Each formulation was stored in 30 ml amber glass bottle at 5 or 25 °C for 90 days. Idebenone contents in these suspensions, determined by a stability-indicating high-performance liquid chromatography method, remained stable at least 90 days in Inorpha when stored at the two temperatures. In Ora-Blend, the stability was estimated at 14 days and in other suspensions at 20 days at the two temperatures. After 90 days storage, the pH of Ora-Plus and Ora-Sweet or Ora-Sweet SF changed between -0.10 and -0.25 units. For others suspensions, the pH changes were not significant (< -0.09 unit). No change was observed in color, odor or visual microbiology. To conclude, we recommended the use of idebenone in Inorpha vehicle stable for at least 90 days at 25 °C.

Keywords: Idebenone; pediatric oral suspensions; stability study.

MeSH terms

  • Administration, Oral
  • Antioxidants / administration & dosage
  • Antioxidants / chemistry*
  • Child
  • Drug Compounding
  • Drug Stability
  • Drug Storage
  • Humans
  • Pharmaceutical Vehicles / chemistry*
  • Suspensions
  • Ubiquinone / administration & dosage
  • Ubiquinone / analogs & derivatives*
  • Ubiquinone / chemistry

Substances

  • Antioxidants
  • Pharmaceutical Vehicles
  • Suspensions
  • Ubiquinone
  • idebenone